CMI
73
-2
JNJ
54
3
SLG
37
6
PEG
50
4
KMB
33
2
EQR
47
2
PNW
57
2
HBAN
82
2
MMC
60
3
URBN
54
2
KO
44
2
VZ
39
2
OKE
64
-3
RF
63
2
OMC
55
-7
KMI
65
-2
CPB
37
2
CNP
55
3
FIS
73
11
TGT
52
2
CMI
73
-2
JNJ
54
3
SLG
37
6
PEG
50
4
KMB
33
2
EQR
47
2
PNW
57
2
HBAN
82
2
MMC
60
3
URBN
54
2
KO
44
2
VZ
39
2
OKE
64
-3
RF
63
2
OMC
55
-7
KMI
65
-2
CPB
37
2
CNP
55
3
FIS
73
11
TGT
52
2
Financhill
Back

Nuveen S&P 500 Dynamic Overwrite Fund Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
50

SPXX
Nuveen S&P 500 Dynamic Overwrite Fund

Last Price:
$18.11
Seasonality Move:
-1.48%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$39.9100
Seasonality Move:
33.23%
Sell
50
Nuveen S&P 500 Dynamic Overwrite Fund (SPXX) is a Sell

Is Nuveen S&P 500 Dynamic Overwrite Fund a Buy, Sell or Hold?

  • The current Nuveen S&P 500 Dynamic Overwrite Fund [SPXX] share price is $18.12. The Score for SPXX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • SPXX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SPXX Stock Price Chart

What is Nuveen S&P 500 Dynamic Overwrite Fund's stock price today?

  • The Nuveen S&P 500 Dynamic Overwrite Fund share price today is $18.12
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPXX is experiencing buying pressure, which is a positive indicator for future bullish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

SPXX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.41 Buy
Relative Strength Index (14 RSI): 60.85 Buy
Chaikin Money Flow: 27401 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.38 - 18.04) Buy
Bollinger Bands (100): (17.4 - 18.08) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

SPXX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.72 Buy
20-day SMA: 17.84 Buy
50-day SMA: 17.61 Buy
200-day SMA: 17.41 Buy
8-day EMA: 12.76 Buy
20-day EMA: 7 Buy
50-day EMA: 3.22 Buy
200-day EMA: 0.87 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Nuveen S&P 500 Dynamic Overwrite Fund Earnings Growth & SPXX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Nuveen S&P 500 Dynamic Overwrite Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):